Formulation Development Outsourcing Market : A Booming Market on the Rise, Expected to Reach USD 51.9 billion by 2031

The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031.

The formulation development outsourcing market refers to the business of outsourcing the development of pharmaceutical formulations to contract development and manufacturing organizations (CDMOs) or contract research organizations (CROs). This market has been growing steadily in recent years, as pharmaceutical companies seek to reduce costs and accelerate drug development timelines by outsourcing various aspects of their R&D processes.

The veterinary imaging market is seeing increasing demand due to the rising prevalence of chronic diseases and infections among animals, especially companion animals such as cats and dogs. The market is also driven by the growing adoption of advanced imaging technologies such as digital radiography, ultrasound, and MRI, which provide more detailed and accurate images for diagnosis and treatment.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/31830

𝐃𝐫𝐢𝐯𝐞𝐫𝐬, 𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬-

Rise in demand for biopharmaceuticals and advanced drug delivery systems drives the growth of the global formulation development outsourcing market. However, structural changes in the pharmaceutical sector and lack of funds to complete the medication development process through formulation development restrain the market growth to some extent. On the other hand, global awareness of vaccines and extensive R&D works have paved the way for lucrative opportunities for the key players in the industry.

𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐨𝐧 𝐅𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐎𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭-

Several countries happened to introduce new measures to thrust the demand for domestic Active Pharmaceutical Ingredient (API), which boosted the global formulation development outsourcing market in several ways.

Rapid advancements in research & development activities also impacted the market positively.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬):
https://www.alliedmarketresearch.com/checkout-final/formulation-development-outsourcing-market

𝐓𝐡𝐞 𝐟𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐫𝐮𝐥𝐞 𝐭𝐡𝐞 𝐫𝐨𝐨𝐬𝐭-

By services type, the formulation development segment held the major share in 2021, accounting for more than half of the global formulation development outsourcing market revenue. This is because formulation development plays a crucial role in creating stable and patient-acceptable drug preparations and forms. The pre-formulation segment, on the other hand, would showcase the fastest CAGR of 9.2% during the forecast period. This is due to the fact that in pre-formulation, the physicochemical qualities of drug materials are described which ease the research process.

𝐓𝐡𝐞 𝐢𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐫𝐞𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐝𝐨𝐦𝐢𝐧𝐚𝐧𝐜𝐞 𝐛𝐲 𝟐𝟎𝟑𝟏-

By route of administration, the injectable segment accounted for the highest share in 2021, holding around three-fourths of the global formulation development outsourcing market revenue. This is owing to the fact that the injectable formulation development is sterile pharmaceutical entities that are administered to the human body via injection. The oral segment, however, would showcase the fastest CAGR of 9.3% by 2031. This is attributed to the introduction of substances using tablets, capsules, and controlled time-release preparations that do not need the assistance of trained professionals.

𝐓𝐡𝐞 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐫𝐮𝐥𝐞 𝐭𝐡𝐞 𝐫𝐨𝐨𝐬𝐭-
By end-user, the pharmaceutical industries segment held around three-fourths of the global formulation development outsourcing market share in 2021, and is projected to dominate by 2031. The same segment would also cite the fastest CAGR of 9.3% from 2022 to 2031. The fact that pharmaceutical industries provide medicines for the individual treatment of various types of diseases propels the growth of the segment.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐚𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/31830

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐠𝐚𝐫𝐧𝐞𝐫𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐬𝐡𝐚𝐫𝐞 𝐢𝐧 𝟐𝟎𝟐𝟏 –

By region, North America contributed to around one-third of the global formulation development outsourcing market share in 2021, and is expected to retain its dominance by 2031. Asia-Pacific, simultaneously, would display the fastest CAGR of 10.4% throughout the forecast period. Advancements in the healthcare and pharmaceutical sector with cutting-edge technological developments fuel the market growth.

𝐅𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐎𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬-

Syngene international limited

Catalent Inc.

Piramal Pharma Limited

Intertek Group PLC

Thermo Fisher Scientific Inc.

Dr Reddy’s Laboratories Ltd.

Charles River Laboratories International Inc.

Eurofins Scientific

Laboratory Corporation of America Holdings

Emergent BioSolutions Inc.

The report analyzes these key players in the global formulation development outsourcing market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, developments, and product portfolios of every market player.

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

Gene Synthesis Market: https://www.alliedmarketresearch.com/gene-synthesis-market-A39015

Mobile Tomography Market: https://www.alliedmarketresearch.com/mobile-tomography-market-A31901

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com